Table 3.
Characteristics and statistical results of the patients grouped according to their chemotherapy history
| Variables | Groups | P value** | ||
|---|---|---|---|---|
|
| ||||
| A: No prior chemotherapy* | B: During chemotherapy* | C: Previous chemotherapy* | ||
| Vertebral-SUV | 1.69 (0.79-3.07) | 1.49 (0.69-2.53) | 1.40 (0.56-2.11) | 0.04 (A vs B) |
| < 0.01 (A vs C) | ||||
| 0.74 (B vs C) | ||||
| Femoral-SUV | 0.68 (0.21-1.85) | 0.70 (0.24-1.13) | 0.63 (0.24-1.63) | 0.76 |
| BM-CT number | -31.0 (-85.3-60.5) | -22.7 (-81.5-13.6) | -33.2 (-78.6-25.1) | 0.35 |
| Age (years) | 66 (22-87) | 69 (44-79) | 65.8 (24-86) | 0.41 |
| Male/female | 74/75 | 11/12 | 20/35 | 0.24*** |
| BS (mg/dL) | 103.1 (76-149) | 102.0 (45-147) | 103.4 (78-139) | 0.92 |
| BW (kg) | 59.3 (35.4-114.1) | 54.1 (40.8-85.5) | 56.5 (30.8-83.5) | 0.18 |
| WBC count (× 103/μL) | 6.20 (3.20-1.72) | 4.47 (1.80-11.10) | 4.78 (1.80-1.89) | < 0.01 (A vs B) |
| 0.04 (A vs C) | ||||
| 0.74 (B vs C) | ||||
| Hgb (mg/dL) | 13.2 (8.0-17.0) | 10.9 (7.8-15.0) | 12.4 (7.6-15.4) | < 0.01 (A vs B) |
| < 0.01 (A vs C) | ||||
| 0.03 (B vs C) | ||||
| Plt count (× 103/μL) | 255.7 (13.6-572.0) | 221.0 (58.0-444.0) | 214.3 (28.0-364.0) | < 0.01 (A vs C) |
| 0.01 (A vs B) | ||||
| 1.00 (B vs C) | ||||
| CRP (mg/dL) | 0.23 (0.01-12.9) | 0.15 (0.01-8.4) | 0.18 (0.02-4.68) | 0.44 |
Values are presented as median (range). SUV, standardized uptake value; BM, bone marrow; CT, computed tomography; BS, blood sugar; BW, body weight; WBC, white blood cell; Hgb, hemoglobin; Plt, platelet; CRP, C-reactive protein.
*
No prior chemotherapy: patients who had never received anticancer chemotherapy; during chemotherapy: patients who had received anticancer chemotherapy within 30 days previously; previous chemotherapy: patients who had received anticancer chemotherapy more than 30 days previously.
**
Results of the Kruskal-Wallis H test and Mann-Whitney U test with Bonferroni correction.
***
Results of the chi-square test.